This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (130)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Venous Thromboembolism  • Pediatric Neurology  • Cardiovascular System  • Alert me on articles by topic  Social Bookmarking   What's this?

Gabrielle deVeber, MD; Paul Monagle, MBBS; Anthony Chan, MBBS; Daune MacGregor, MD; Rosalind Curtis, MD; Sharon Lee, BSc; Patricia Vegh; Margaret Adams; Velma Marzinotto, BScN; Michael Leaker, MD; M. Patricia Massicotte, MD; David Lillicrap, MD; Maureen Andrew, MD

Arch Neurol. 1998;55:1539-1543.

Background  To our knowledge, the contribution of prothrombotic conditions to cerebral thromboembolism has never been prospectively studied in a large series of pediatric patients.

Methods  The Hospital for Sick Children, Toronto, Ontario, established a program in January 1992 to diagnose and treat children (term newborn to 18 years old) with arterial ischemic stroke or sinovenous thrombosis. The routine evaluation for prothrombotic conditions included plasminogen, antithrombin, protein C, free protein S, activated protein C resistance, IgG and IgM anticardiolipin antibody, and lupus anticoagulant. We analyzed samples taken within 2 years of the event. We report results on patients seen from January 1, 1992, to January 1, 1997.

Results  Ninety-two patients (47 males and 45 females) entered the program during the study interval. Patients ranged from newborn to 18 years in age. Arterial ischemic stroke occurred in 78% of patients while sinovenous thrombosis occurred in 22%. All were tested for prothrombotic disorders. One or more abnormal results were present in 35 (38%) of the 92 patients. The majority (21/35) had multiple abnormal test results. The abnormal test results were anticardiolipin antibody (33%), plasminogen (9.5%), activated protein C resistance (9%), protein C (7%), antithrombin (12.5%), lupus anticoagulant (8%), and free protein S (11.5%). Male sex predicted the presence of prothrombotic abnormalities (relative risk, 1.7; 95% confidence interval, 1.2-2.5), but stroke type (relative risk, 0.8; 95% confidence interval, 0.7-1.1), age group, and presence of other risk factors did not predict abnormal testing.

Conclusions  A significant proportion (38%) of children with cerebral thromboembolism had evidence of prothrombotic conditions. In particular, there was a predominance of children with anticardiolipin antibody (33%). These data support a recommendation that children with cerebral thromboembolism be evaluated for prothrombotic disorders.

From Hamilton Civic Hospitals Research Center (Drs deVeber, Monagle, Chan, and Andrew and Mss Lee, Vegh, and Adams) and the Department of Pediatrics, McMaster University, Hamilton, Ontario (Drs deVeber and Chan); the Divisions of Neurology (Drs deVeber, MacGregor, and Curtis) and Hematology/Oncology (Mss Adams and Marzinotto, and Drs Leaker, Massicotte, and Andrew), The Hospital for Sick Children, Toronto, Ontario; and Richardson Laboratory, Queen's University, Kingston, Ontario (Dr Lillicrap).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis: A Cohort Study
Gabrielle deVeber, Anthony Chan, Paul Monagle, Velma Marzinotto, Derek Armstrong, Patricia Massicotte, Michael Leaker, and Maureen Andrew
Arch Neurol. 1998;55(12):1533-1537.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neonatal Stroke Is Not a Harmless Condition
Aden
Stroke 2009;40:1948-1949.
FULL TEXT  

Pediatric Stroke in the United States and the Impact of Risk Factors
Lo et al.
J Child Neurol 2009;24:194-203.
ABSTRACT  

Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies
Young et al.
Circulation 2008;118:1373-1382.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Monagle et al.
Chest 2008;133:887S-968S.
ABSTRACT | FULL TEXT  

Human Infection with Fusobacterium necrophorum (Necrobacillosis), with a Focus on Lemierre's Syndrome
Riordan
Clin. Microbiol. Rev. 2007;20:622-659.
ABSTRACT | FULL TEXT  

Arterial Ischemic Stroke in Childhood: Risk Factors and Outcome in Old Versus New Era
Gokben et al.
J Child Neurol 2007;22:1204-1208.
ABSTRACT  

Significance of Factor V, Prothrombin, MTHFR, and PAI-1 Genotypes in Childhood Cerebral Thrombosis
Ozyurek et al.
CLIN APPL THROMB HEMOST 2007;13:154-160.
ABSTRACT  

Arterial Ischemic Stroke in a Child with {beta}-Thalassemia Trait and Methylentetrahydrofolate Reductase Mutation
Brankovic-Sreckovic et al.
J Child Neurol 2007;22:208-210.
ABSTRACT  

Different Additional Risk Factors for Cerebral Infarctions Associated With the Factor V Leiden Mutation in a Family
Vagiakou et al.
J Child Neurol 2006;21:903-907.
ABSTRACT  

My approach to performing a perinatal or neonatal autopsy.
Wainwright
J. Clin. Pathol. 2006;59:673-680.
ABSTRACT | FULL TEXT  

Stroke in Childhood: Experience in Istanbul, Turkey
Aydinli et al.
J Trop Pediatr 2006;52:158-162.
ABSTRACT | FULL TEXT  

Pathways of neonatal stroke and subclavian steal syndrome.
Beattie et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2006;91:F204-F207.
ABSTRACT | FULL TEXT  

Urgent Clinical Challenges in Children With Ischemic Stroke: Analysis of 1065 Patients From the 1-800-NOCLOTS Pediatric Stroke Telephone Consultation Service
Kuhle et al.
Stroke 2006;37:116-122.
ABSTRACT | FULL TEXT  

Prothrombotic Factors in Children With Stroke or Porencephaly
Lynch et al.
Pediatrics 2005;116:447-453.
ABSTRACT | FULL TEXT  

Genetic Risk Factors Associated With Thrombosis in Children With Congenital Neurologic Disorders
Tzoufi et al.
J Child Neurol 2005;20:509-512.
ABSTRACT  

Genetic Risk Factors Associated With Thrombosis in Children With Congenital Neurologic Disorders
Tzoufi et al.
J Child Neurol 2005;20:509-512.
ABSTRACT  

Thrombophilia and first arterial ischaemic stroke: a systematic review
Haywood et al.
Arch. Dis. Child. 2005;90:402-405.
ABSTRACT | FULL TEXT  

Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome
Sebire et al.
Brain 2005;128:477-489.
ABSTRACT | FULL TEXT  

Factor V Leiden Mutation and Other Thrombophilia Markers in Childhood Ischemic Stroke
Duran et al.
CLIN APPL THROMB HEMOST 2005;11:83-88.
ABSTRACT  

Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Monagle et al.
Chest 2004;126:645S-687S.
ABSTRACT | FULL TEXT  

Pediatric Stroke Among Hong Kong Chinese Subjects
Chung and Wong
Pediatrics 2004;114:e206-e212.
ABSTRACT | FULL TEXT  

Acute Myocardial Infarction in a Child: Possible Pathogenic Role of Patent Foramen Ovale Associated With Heritable Thrombophilia
Carano et al.
Pediatrics 2004;114:e255-e258.
ABSTRACT | FULL TEXT  

Back to school on APS: Rethinking the risk of recurrent stroke in children
Fullerton and von Scheven
Neurology 2004;62:172-173.
FULL TEXT  

Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children
Lanthier et al.
Neurology 2004;62:194-200.
ABSTRACT | FULL TEXT  

Recurrent Thromboembolism in Infants and Children Suffering From Symptomatic Neonatal Arterial Stroke: A Prospective Follow-Up Study
Kurnik et al.
Stroke 2003;34:2887-2892.
ABSTRACT | FULL TEXT  

Cerebral Venous Thrombosis in Children: A Multifactorial Origin
Heller et al.
Circulation 2003;108:1362-1367.
ABSTRACT | FULL TEXT  

Multiple risk factors in neonatal sinovenous thrombosis
Wu et al.
Neurology 2002;59:438-440.
ABSTRACT | FULL TEXT  

Deaths from stroke in US children, 1979 to 1998
Fullerton et al.
Neurology 2002;59:34-39.
ABSTRACT | FULL TEXT  

Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients: A Prospective Follow-Up Study
Strater et al.
Stroke 2001;32:2554-2558.
ABSTRACT | FULL TEXT  

Cerebrovascular Disorders in Children With the Factor V Leiden Mutation
Lynch et al.
J Child Neurol 2001;16:735-744.
ABSTRACT  

Cerebral Sinovenous Thrombosis in Children
deVeber et al.
NEJM 2001;345:417-423.
ABSTRACT | FULL TEXT  

Cerebral Venous Thrombosis in Children
Carvalho et al.
J Child Neurol 2001;16:574-580.
ABSTRACT  

Prothrombotic Disorders in Children With Moyamoya Syndrome Editorial Comment
Bonduel et al.
Stroke 2001;32:1786-1792.
ABSTRACT | FULL TEXT  

Prothrombotic Disorders and Abnormal Neurodevelopmental Outcome in Infants With Neonatal Cerebral Infarction
Mercuri et al.
Pediatrics 2001;107:1400-1404.
ABSTRACT | FULL TEXT  

Thromboembolic Disease and Antithrombotic Therapy in Newborns
Andrew et al.
ASH Education Book 2001;2001:358-374.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Children
Monagle et al.
Chest 2001;119 :344S-370S.
FULL TEXT  

Symptomatic Ischemic Stroke in Full-Term Neonates : Role of Acquired and Genetic Prothrombotic Risk Factors
Gunther et al.
Stroke 2000;31:2437-2441.
ABSTRACT | FULL TEXT  

Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children
Kenet et al.
Stroke 2000;31:1283-1288.
ABSTRACT | FULL TEXT  

Risk Factors for Arterial Ischemic Stroke in Children
Kirkham et al.
J Child Neurol 2000;15:299-307.
ABSTRACT  

Stroke in Children: Genetic and Metabolic Issues
Pavlakis et al.
J Child Neurol 2000;15:308-315.
ABSTRACT  

Stroke in children: The coexistence of multiple risk factors predicts poor outcome
Lanthier et al.
Neurology 2000;54:371-371.
ABSTRACT | FULL TEXT  

Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood
Nowak-Gottl et al.
Blood 1999;94:3678-3682.
ABSTRACT | FULL TEXT  

Stroke in childhood
Kirkham
Arch. Dis. Child. 1999;81:85-89.
FULL TEXT